At a glance
ClinicalIndex Comparison RecordN/ACompleted· 102 enrolled
Drug / intervention
gammaCoredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Multicentre, Double-blind, Parallel, Sham-controlled Study of GammaCore®, a Non-invasive Neurostimulator Device for the Acute Relief of Episodic and Chronic Cluster Headache.
In Brief
A clinical study evaluating gammaCore for Cluster Headache. Completed, enrolled 102 participants across 9 sites in 4 countries.
Detailed Summary
The study will look at a non-invasive treatment for people suffering with chronic and episodic headaches. Study subjects will be randomized to an active treatment or an in-active treatment for 2 weeks. After the 2 weeks all subjects will continue to treat with an active treatment for an additional 2 weeks.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCluster Headache
CountriesDenmark, Germany, Netherlands, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartAug 2013
First PostedOct 2013
Primary CompletionOct 2014
Study CompletionJan 2015
TodayJul 2026
First PostedOct 8, 2013
Enrollment StartAug 1, 2013
Primary CompletionOct 1, 2014
Study CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 12.7 years ago
Interventions
gammaCoredevice
Vagal stimulation